.

ISSN 2063-5346
For urgent queries please contact : +918130348310

AN OVERVIEW; SCREENING FOR PREECLAMPSIA IN PREGNANCY AND RISK FOR GROWTH RESTRICTION, ROLE OF NURSING AND PHARMACIST IN MANAGEMENT APPROACH

Main Article Content

Dr.Fayzah Ahmed Andegani, Dr.Abrar Talal Omar Kerdawi, Dr.Iman Ahmad Nashawi,Dr.Bayan Ali Ahmed Alomari, Dr.Aishah Ayoub Allah Bakhsh Woryaam, Dr.Rayan Mussa Saleh Althagafi, Asmahan Farag Alenezi, Suhair Muhammad Rashid Al-Sulaimani, Abdullah Hasan Alzahrani, Sharaa Mohammad Saeed Al Amri, Haya Houmood Albeshi, Rawan Sami Alharbi, Anan Abdulrahman Fatani, Raed Mohammed Almehmadi, Hattan Smeer Mashat
» doi: 10.53555/ecb/2022.11.5.035

Abstract

It is a hypertension condition that manifests itself during pregnancy and is known as preeclampsia. The early identification and quick management of preeclampsia are necessary in order to reduce morbidity and death associated with the condition. The involvement of nurses and pharmacists in approaching care and drug adherence is also important. When it comes to making decisions about the use of medicine during pregnancy, a community pharmacist is typically the first healthcare practitioner that is contacted for help. A woman frequently finds out she is pregnant when she is already taking a drug, and she goes to a pharmacy that is conveniently accessible in order to inquire about whether or not she has caused harm to her unborn child by taking the prescription. This is because fifty percent of pregnancies are unplanned. It may be concluded that beginning low-dose aspirin treatment during the early stages of pregnancy is an effective technique for lowering the risk of developing preeclampsia and intrauterine growth restriction (IUGR).

Article Details